Register Now
✉ drparkerarmc@gmail.com
☎ office: (806) 410-6584
  • HOME
  • ABOUT US
  • TESTIMONIALS
  • FREE SEMINAR
    • EVENTS CALENDAR | Amarillo Regenerative Medicine Center
    • REGISTRATION | Amarillo Regenerative Medicine Center
  • CONDITIONS
  • TREATMENTS
  • RESEARCH
    • UMBILICAL CORD & WHARTON'S JELLY
    • NEUROPATHY
    • ORTHOPEDIC CONDITIONS & SPORTS INJURIES
    • ADDITIONAL RESEARCH
  • BLOG
  • CONTACT

ERECTILE DYSFUNCTION

ED (Erectile Dysfunction) 

BDNF-hypersecreting human umbilical cord blood mesenchymal stem cells promote erectile function in a rat model of cavernous nerve electrocautery injury


Erectile dysfunction (ED) continues to be a significant problem for men following radical prostatectomy.  This study concluded that intracavernous injection of BDNF-hypersecreting human umbilical cord mesenchymal stem cells (hUCB-MSCs) can enhance the recovery of erectile function, promote the cavernous nerves regeneration and inhibit corpus cavernosum fibrosis after cavernous nerve electrocautery injury in a rat model.


Read Research

Erectile dysfunction treated with intracavernous stem cells: A promising new therapy?


In the past decades, great interest has been shown in the development of new therapies for erectile dysfunction. Stem cell therapy has generated promising results in numerous preclinical trials in animal models, which is why it has led to the development of the first clinical trials in humans.


The main cause involved in the pathophysiology of erectile dysfunction is vascular damage related to endothelial and neuronal injury. The interest in stem cell therapy is justified by their capability to differentiate into specific damaged tissues, including endothelium and nervous tissue, and induction of the host own cell proliferation.


Read Research

Stem-cell therapy for erectile dysfunction


Erectile dysfunction (ED) is the most common sexual disorder that men report to healthcare providers, and is the male sexual dysfunction that has been most investigated. Current treatments for ED focus on relieving the symptoms of ED and therefore tend to provide a temporary solution rather than a cure or reversing the cause.


The rapidly expanding and highly promising body of preclinical work on SC-based medicine providing a potential cure for ED, rather than merely symptom relief, is indicative of the increasing interest in regenerative options for sexual medicine over the past decade. Clinical trials are currently recruiting patients to test the preclinical results in men with ED.


Read Research

Stem Cell Therapy for Erectile Dysfunction: Progress and Future Directions


Currently, the treatment of ED focuses on symptomatic relief of ED and therefore tends to provide temporary relief rather than providing a cure or reversing the underlying cause. Recently, stem cell-based therapies have received increasing attention regarding their potential for the recovery of erectile function. Preclinical studies have shown that these cells may reverse pathophysiological changes leading to ED rather than treating the symptom ED.


The development of methods to deliver stem cells to the penis has kindled a keen interest in understanding stem cell biology as it related to restoration of normal penile vascular and neuronal homeostasis. The use of stem cells for the treatment of ED represents an exciting new field.


Read Research

New LMultipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunctionist Item


Erectile dysfunction (ED) following radical prostatectomy (RP) is a result of inadvertent damage to the cavernous nerves that run close to the prostate capsula. Multipotent stromal cells (MSCs) are an attractive cell source for this application based on their regenerative potential and their clinical applicability. MSCs from both bone marrow and adipose tissue have shown beneficial effects in a variety of animal models for ED.  While the type of model may influence the mechanisms of action of this MSC-based therapy, MSCs generally display efficacy in various animal models for ED.


Read Research

New List IteStem cell therapies in post-prostatectomy erectile dysfunction: a critical reviewm


Erectile dysfunction (ED) is still a common complication of radical prostatectomy. Current treatments of ED are mainly symptomatic. Mesenchymal stem cells (MSCs) have been widely investigated as a potential curative treatment. MSC therapy consistently improved erectile functions after cavernous nerve injury (CNI). There seems to be a consensus on the disease model used and outcome evaluation however further studies should be done.


Read Research

Advances in stem cell research for the treatment of male sexual dysfunctions


This review summarizes recent literature on basic stem cell research in erectile dysfunction in cavernous nerve injury, aging, diabetes, and Peyronie’s disease and to provide a perspective on clinical translation of these cellular therapies.  In summary, evidence from preclinical studies has established stem cells as a potential curative treatment for erectile dysfunction and early phase clinical trials are currently performed.


Read Research

Stem Cells in Male Sexual Dysfunction: Are We Getting Somewhere?New List Item


Stem cells for sexual disorders are steadily being introduced into clinical trials. Two conditions of importance are the main target for this line of treatment, especially when regarding the wide array of translational and basic science highlighting the potential advantages of regenerative therapy: erectile dysfunction (ED) and more recently Peyronie disease (PD). Cellular therapy offers a treatment modality that might reverse disease progression. It would be used in a curative setting, in contrast to other pharmaceutical agents that are currently available.


This study concludes that stem cells have an established efficacy in preclinical studies and early clinical trials. Studies are currently being published demonstrating the safety of intrapenile injection of autologous bone marrow- and adipose tissue-derived stem cells.


Read Research

MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury


MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury.


Read Research
  • HOME
  • ABOUT US
  • TESTIMONIALS
  • FREE SEMINAR
    • EVENTS CALENDAR | Amarillo Regenerative Medicine Center
    • REGISTRATION | Amarillo Regenerative Medicine Center
  • CONDITIONS
  • TREATMENTS
  • RESEARCH
    • UMBILICAL CORD & WHARTON'S JELLY
    • NEUROPATHY
    • ORTHOPEDIC CONDITIONS & SPORTS INJURIES
    • ADDITIONAL RESEARCH
  • BLOG
  • CONTACT
  • HOME
  • ABOUT US
  • TESTIMONIALS
  • FREE SEMINAR
    • EVENTS CALENDAR | Amarillo Regenerative Medicine Center
    • REGISTRATION | Amarillo Regenerative Medicine Center
  • CONDITIONS
  • TREATMENTS
  • RESEARCH
    • UMBILICAL CORD & WHARTON'S JELLY
    • NEUROPATHY
    • ORTHOPEDIC CONDITIONS & SPORTS INJURIES
    • ADDITIONAL RESEARCH
  • BLOG
  • CONTACT

1934 Civic Circle

Amarillo, TX 79109

☎ office: (806) 410-6584

☎ seminar: (806)410-6584

✉ drparkerarmc@gmail.com

© 2020 All Rights Reserved | Regenerative Medicine of Amarillo

Privacy Policy

Share by: